# Use of Transvenous Pacing Wire During Minimally Invasive Port Access Aortic Valve Surgery

Study · id `cardio:ct-nct01631188` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01631188](<https://clinicaltrials.gov/study/NCT01631188>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01631188

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 100 participants.

## Technical summary

Registry record NCT01631188. Allocation not applicable; no masking; primary purpose other. Start 2011-12 (registry gives no type); primary completion 2015-12 (actual). Results posted on 2021-11-16.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT01631188, source copy `cardio:ctgov-nct01631188-2021-11-16`, retrieved 2026-10-26)
- Start date: 2011-12 (registry gives no type) (ClinicalTrials.gov record NCT01631188, source copy `cardio:ctgov-nct01631188-2021-11-16`, retrieved 2026-10-26)
- Primary completion: 2015-12 (actual) (ClinicalTrials.gov record NCT01631188, source copy `cardio:ctgov-nct01631188-2021-11-16`, retrieved 2026-10-26)
- Completion: 2015-12 (actual) (ClinicalTrials.gov record NCT01631188, source copy `cardio:ctgov-nct01631188-2021-11-16`, retrieved 2026-10-26)
- Results first posted: 2021-11-16 (ClinicalTrials.gov record NCT01631188, source copy `cardio:ctgov-nct01631188-2021-11-16`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01631188-2021-11-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Use of Transvenous Pacing Wire During Minimally Invasive Port Access Aortic Valve Surgery
- Condition: Aortic Valve Disease
- Intervention (Procedure): Minimally Invasive Aortic Valve
- Intervention (Procedure): Minimally Invasive Aortic Valve Surgery
- Intervention (Device): Manipulation in OR surgical technique
- Lead sponsor: Rutgers, The State University of New Jersey
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Rutgers, The State University of New Jersey (`cardio:org-rutgers-the-state-university-of-new-jersey`)

## Provenance

Content hash: 215300ed977a8710be14c6e4a6fdb3071f1be819bbe22fad6e79b4385b6bc692
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
